Oncology & Cancer

Dual-modality DRS-FS discerns tumor from surrounding tissue

(HealthDay)—Dual-modality diffuse reflectance spectroscopy-fluorescence spectroscopy (DRS-FS) can differentiate tumor tissue from surrounding tissue in patients undergoing colorectal cancer resection, according to a study ...

Oncology & Cancer

Subsequent neoplasm risk up for decades in child CA survivors

(HealthDay)—Survivors of childhood cancer are at increased risk for treatment-related subsequent neoplasms (SNs), even after age 40 years, according to a study published online Aug. 10 in the Journal of Clinical Oncology.

Oncology & Cancer

Endoscopic cancer detection in real time

Cancer or no cancer? This question can usually only be answered after a days-long wait for a histological examination. With the use of a mass spectrometric technique, the answer may soon be available in real time. In the ...

Oncology & Cancer

Survival from rare bone cancer remains low

Among the deadliest cancers is a rare malignancy called mesenchymal chondrosarcoma, which begins in cartilage around bones and typically strikes young adults.

Oncology & Cancer

Improving cancer treatment through better imaging technologies

Since January 2014, the HELICOID project has been developing hyperspectral imaging technologies capable of differentiating between healthy and diseased tissues. The February 2015 meeting in Brussels enabled project partners ...

page 3 from 8